Mo et al. showed high levels of CCR5 and CXCR3 in IL-17-producing Vδ2+ cells driven by the TNF-α-induced NF-κB signaling pathway in the serum of RA patients (81). This evidence concerns the gene IL17A and rheumatoid arthritis.